See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2018_Zyla_Life_Sciences.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,953,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,583,000 |
| 2 | PropertyPlantAndEquipmentNet | 9,911,000 |
| 3 | remainder_Assets | 1,411,000 |
| 4 | LiabilitiesCurrent | 42,967,000 |
| 5 | LiabilitiesNoncurrent | 99,617,000 |
| 6 | remainder_Liabilities | 16,649,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 38,136,216 |
| 9 | ResearchAndDevelopmentExpense | 14,469,555 |
| 10 | remainder_Expenses | 70,655,229 |
| 11 | remainder_Revenues | 24,087,909 |
| 12 | remainder_NetIncome | -5,438,902 |
| 13 | remainder_ComprehensiveNetIncome | 648,122 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 119,858,000 |
| 1 | Liabilities | 159,233,000 |
| 2 | Expenses | 123,261,000 |
| 3 | Revenues | 24,087,909 |
| 4 | StockholdersEquity | -39,375,000 |
| 5 | NetIncome | -104,611,993 |
| 6 | ComprehensiveNetIncome | -104,287,932 |
| 7 | BaseVar | 216,263,466 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.36 |
| 9 | EconomicCapitalRatio | 1.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
